Skip to main content
TipRanks
Go Ultimate75% OFF

Veracyte (VCYT) Stock Statistics & Valuation Metrics

623 Followers

Total Valuation

Veracyte has a market cap or net worth of $1.94B. The enterprise value is $3.48B.

Market Cap
$1.94B
Enterprise Value
$3.48B

Share Statistics

Veracyte has 80,695,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
80,695,480
Owned by Insiders
1.69%
Owned by Institutions
93.11%

Financial Efficiency

Veracyte’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 5.34%.

Return on Equity (ROE)
0.05
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
5.34%
Return on Capital Employed (ROCE)
0.06
Revenue Per Employee
684.96K
Profits Per Employee
87.88K
Employee Count
755
Asset Turnover
0.37
Inventory Turnover
7.65

Valuation Ratios

The current PE Ratio of Veracyte is 15.17. Veracyte’s PEG ratio is 0.05.

PE Ratio
15.17
PS Ratio
3.35
PB Ratio
1.35
Price to FCF
12.06
Price to Operating Cash Flow
11.17
PEG Ratio
0.05

Income Statement

In the last 12 months, Veracyte had revenue of 517.14M and earned 66.35M in profits. Earnings per share was 0.84.

Revenue
517.14M
Gross Profit
360.05M
Operating Income
74.15M
Pretax Income
68.20M
Net Income
66.35M
EBITDA
89.62M
Earnings Per Share (EPS)
0.84

Cash Flow

In the last 12 months, operating cash flow was 173.88M and capital expenditures -12.47M, giving a free cash flow of 161.41M billion.

Operating Cash Flow
173.88M
Free Cash Flow
161.41M
Free Cash Flow per Share
2.01

Dividends & Yields

Veracyte pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
8.33%
Earnings Yield
6.56%

Stock Price Statistics

Beta
1.26
52-Week Price Change
-38.98%
50-Day Moving Average
42.16
200-Day Moving Average
42.47
Relative Strength Index (RSI)
27.79
Average Volume (3m)
1.80M

Important Dates

Veracyte upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
Mar 01, 2027
Ex-Dividend Date
―

Financial Position

Veracyte as a current ratio of 8.15, with Debt / Equity ratio of 3.03%

Current Ratio
8.15
Quick Ratio
7.81
Debt to Market Cap
0.00
Net Debt to EBITDA
-3.60
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Veracyte has paid 1.85M in taxes.

Income Tax
1.85M
Effective Tax Rate
0.03

Enterprise Valuation

Veracyte EV to EBITDA ratio is 13.40, with an EV/FCF ratio of 11.02.

EV to Sales
3.06
EV to EBITDA
13.40
EV to Free Cash Flow
11.02
EV to Operating Cash Flow
10.23

Balance Sheet

Veracyte has $370.53M in cash and marketable securities with $40.74M in debt, giving a net cash position of $329.80M billion.

Cash & Marketable Securities
$370.53M
Total Debt
$40.74M
Net Cash
$329.80M
Net Cash Per Share
$4.09
Tangible Book Value Per Share
$4.88

Margins

Gross margin is 72.35%, with operating margin of 15.36%, and net profit margin of 21.80%.

Gross Margin
72.35%
Operating Margin
15.36%
Pretax Margin
19.11%
Net Profit Margin
21.80%
EBITDA Margin
22.81%
EBIT Margin
19.11%

Analyst Forecast

The average price target for Veracyte is $45.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$45.00
Price Target Upside
87.42% Upside
Analyst Consensus
Strong Buy
Analyst Count
10
Revenue Growth Forecast
17.50%
EPS Growth Forecast
311.25%

Scores

Smart Score
8
AI Score
70